我公司专注于肿瘤免疫和炎症疾病的抗体药物的研发，通过对全新靶点或者创新性组合的药物开发，为患者提供高精准、高质量及高效的全新性治疗。公司的发展愿景是创建全球一流的创新性免疫治疗制药公司。公司拥有世界一流的药物研究和转化医学的科研水平，以及丰富的研发基础和资源。
X-Kang United Company was founded in Nov. 2015, the headquarters is based in BioBAY of Suzhou. X-Kang is a biopharmaceutical company to research innovative and effective antibody medicines for cancer and autoimmune diseases. X-Kang' s core scientific team members have strong educational backgrounds and rich drug innovation experiences. We rooted in China with the global vision to discover and develop novel treatments for cancer and autoimmune diseases.
Company Details
- Employees
- 4
- Founded
- -
- Address
- 海淀区开拓路5号, 北京市,北京市 100084,china
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- x-kang.com
- Keywords
- 生物医药, 抗体新药, 肿瘤免疫治疗, 自身免疫性疾病免疫治疗.
- HQ
- 北京市, 北京市
苏州鑫康合生物医药科技有限公司 Questions
苏州鑫康合生物医药科技有限公司's website is x-kang.com
苏州鑫康合生物医药科技有限公司's LinkedIn profile is https://cn.linkedin.com/company/x-kang
苏州鑫康合生物医药科技有限公司 has
4 employees.
View email and phone details for 4
employees at 苏州鑫康合生物医药科技有限公司.
苏州鑫康合生物医药科技有限公司's industry is
Pharmaceutical Manufacturing
苏州鑫康合生物医药科技有限公司's top competitors are
Qingdao Qianshan Science And Technology Innovation Co., Ltd,
Imagene Biopharmaceuticals,
Talent One Consulting,
Jemincare,
Alpha Biopharma,
康诺亚生物医药科技(成都)有限公司,
Zhejiang Jingxin Pharmaceutical Co., Ltd.,
Oricell Therapeutics,
000,
云顶新耀医药科技有限公司.
苏州鑫康合生物医药科技有限公司's categories are Pharmaceutical Manufacturing
苏州鑫康合生物医药科技有限公司's founding year is 2015
